blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2694102

EP2694102 - METHODS OF IMPROVING VACCINE IMMUNOGENICITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.11.2018
Database last updated on 03.10.2024
FormerGrant of patent is intended
Status updated on  06.02.2018
Most recent event   Tooltip09.11.2018Application deemed to be withdrawnpublished on 12.12.2018  [2018/50]
Applicant(s)For all designated states
University of Iowa Research Foundation
Iowa Centers for Enterprise
112 N. Capitol Street
6 Gilmore Hall
Iowa City, IA 52242-5500 / US
[N/P]
Former [2014/07]For all designated states
University of Iowa Research Foundation
112 N. Capitol Street
6 Gilmore Hall
Iowa City, IA 52242-5500 / US
Inventor(s)01 / BISHOP, Gail
UNIVERSITY OF IOWA RESEARCH FOUNDATION
112N Capitol Street
6 Gilmore Hall
Iowa City, IA 52242-5500 / US
02 / VANDEN BUSH, Tony
UNIVERSITY OF IOWA RESEARCH FOUNDATION
112N Capitol Street
6 Gilmore Hall
Iowa City, IA 52242-5500 / US
 [2014/07]
Representative(s)Elbel, Michaela
PATERIS
Patentanwälte PartmbB
Postfach 33 07 11
80067 München / DE
[N/P]
Former [2014/07]Elbel, Michaela
Pateris Patentanwälte Partnerschaft Altheimer Eck 13
80331 München / DE
Application number, filing date12768304.304.04.2012
WO2012US32190
Priority number, dateUS201161471553P04.04.2011         Original published format: US 201161471553 P
[2014/07]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012138774
Date:11.10.2012
Language:EN
[2012/41]
Type: A2 Application without search report 
No.:EP2694102
Date:12.02.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 11.10.2012 takes the place of the publication of the European patent application.
[2014/07]
Search report(s)International search report - published on:US27.02.2014
(Supplementary) European search report - dispatched on:EP02.02.2015
ClassificationIPC:A61K39/00, A61K38/00, A61K39/12, A61K39/13, A61K39/145, A61K39/29, A61K39/39
[2015/10]
CPC:
A61K39/13 (EP,KR,US); C07K14/005 (KR,US); A61K39/12 (EP,US);
A61K39/145 (EP,KR,US); A61K39/292 (EP,KR,US); A61K39/385 (EP,KR,US);
A61P25/00 (EP,KR); A61P31/00 (EP); A61P31/04 (EP);
A61P31/10 (EP); A61P31/12 (EP); A61P31/14 (EP);
A61P31/16 (EP); A61P31/20 (EP); A61P33/00 (EP);
A61P35/00 (EP); A61P37/02 (EP); A61P37/04 (EP);
A61K2039/55505 (EP,KR,US); A61K2039/6012 (EP,KR,US); A61K2039/6037 (EP,KR,US);
A61K2039/6075 (EP,KR,US); C12N2730/10134 (EP,KR,US); C12N2760/16134 (EP,KR,US);
C12N2770/32042 (EP,KR,US); Y02A50/30 (EP,KR,US) (-)
Former IPC [2014/17]A61K39/12, A61K38/00, A61K39/00
Former IPC [2014/07]A61K39/13
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/07]
TitleGerman:VERFAHREN FÜR VERBESSERTE IMPFSTOFF-IMMUNOGENITÄT[2014/07]
English:METHODS OF IMPROVING VACCINE IMMUNOGENICITY[2014/07]
French:PROCÉDÉS D'AMÉLIORATION DE L'IMMUNOGÉNICITÉ DE VACCIN[2014/07]
Entry into regional phase04.11.2013National basic fee paid 
04.11.2013Search fee paid 
04.11.2013Designation fee(s) paid 
04.11.2013Examination fee paid 
Examination procedure04.11.2013Examination requested  [2014/07]
31.08.2015Amendment by applicant (claims and/or description)
09.02.2016Despatch of a communication from the examining division (Time limit: M06)
19.08.2016Reply to a communication from the examining division
05.12.2017Cancellation of oral proceeding that was planned for 13.12.2017
13.12.2017Date of oral proceedings (cancelled)
07.02.2018Communication of intention to grant the patent
19.06.2018Application deemed to be withdrawn, date of legal effect  [2018/50]
26.07.2018Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2018/50]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.02.2016
Fees paidRenewal fee
28.04.2014Renewal fee patent year 03
27.04.2015Renewal fee patent year 04
27.04.2016Renewal fee patent year 05
27.04.2017Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.04.201807   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9214489  (REPLIGEN CORP [US]) [X] 1,13-15 * page 1, lines 6-18; claims 1-19 * * page 15, lines 3-10 *;
 [YP]WO2011041691  (UNIV IOWA RES FOUND [US], et al) [YP] 1-15* page 13, lines 1-8; claims 1-41 *;
 [Y]  - KURIKKA S ED - BETSCH CORNELIA SACHSE KATHARINA, "Priming with diphtheria--tetanus--pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy", VACCINE, ELSEVIER LTD, GB, (19960901), vol. 14, no. 13, doi:10.1016/S0264-410X(96)00025-4, ISSN 0264-410X, pages 1239 - 1242, XP004069593 [Y] 1-15 * table 1 *

DOI:   http://dx.doi.org/10.1016/S0264-410X(96)00025-4
International search[X]US2007026502  (SALLBERG MATTI [SE], et al);
 [Y]US2008090225  (KIRKEGAARD KARLA A [US], et al);
 [A]US2008118530  (KEW OLEN M [US], et al);
 [A]US2010145015  (GALILI URI [US]);
 [A]US2010249021  (GAO GEORGE FU [CN], et al);
 [A]US2010254945  (GE QING [US], et al);
 [A]  - MARTIN ET AL., "Transport of Incoming Influenza Virus Nucleocapsids into the Nucleus.", J VIROL., (1991), vol. 65, no. 1, pages 232 - 244, XP025481483

DOI:   http://dx.doi.org/10.1016/0962-8924(92)90130-F
by applicantUS3773919
 EP0058481
 EP0133988
 US4559157
 US4608392
 US4816567
 US4820508
 US4873192
 US4938949
 US4946778
 EP0404097
 US4992478
 US5091513
 WO9214489
 WO9311161
 US5260203
 US5350674
 US5455030
 US5585362
 US5939598
 US2007026502
    - KURIKKA, Vaccine, (19960000), vol. 14, no. 13, pages 1239 - 1242
    - "Genebank", Database accession no. ABI36003
    - "Genebank", Database accession no. ADY00024.1
    - "Genebank", Database accession no. ADY00020.1
    - "Genebank protein", Database accession no. ABI36003
    - HJELM, F. et al., Scand J Immunol, (20060000), vol. 64, pages 177 - 184
    - HIRSH, DC; MACLACHLAN, NJ; WALKER, RL., Veterinary Microbiology, Blackwell Publishing
    - MCGHEE, J.R. et al., "On vaccine development", Sem. Hematol., (19930000), vol. 30, pages 3 - 15
    - NEEDLEMAN; WUNSCH, J. Mol. Biol., (19700000), vol. 48, page 443
    - KUNKEL, Proc. Natl. Acad. Sci. USA, (19850000), vol. 82, page 488
    - KUNKEL et al., Meth. Enzymol., (19870000), vol. 154, page 367
    - KOHLER; MILSTEIN, Nature, (19750000), vol. 256, page 495
    - CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628
    - MARKS et al., J. Mol. Biol., (19910000), vol. 222, pages 581 - 597
    - MORRISON et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6851 - 6855
    - MCCAFFERTY et al., Nature, (19900000), vol. 348, pages 552 - 554
    - MARKS et al., Bio/Technology, (19920000), vol. 10, pages 779 - 783
    - WATERHOUSE et al., Nucleic Acids Res., (19930000), vol. 21, pages 2265 - 2266
    - JONES et al., Nature, vol. 321, pages 522 - 525
    - MORIMOTO et al., Journal of Biochemical and Biophysical Methods, (19920000), vol. 24, pages 107 - 117
    - BRENNAN et al., Science, (19850000), vol. 229, page 81
    - CO, M. S. et al., J. Immunol., (19940000), vol. 152, pages 2968 - 2976
    - BETTER, M.; HORWITZ, A. H., Methods in Enzymology, Academic Press, Inc., (19890000), vol. 178, pages 476 - 496
    - PLUECKTHUN, A.; SKERRA, A., Methods in Enzymology, Academic Press, Inc., (19890000), vol. 178, pages 476 - 496
    - LAMOYI, E., Methods in Enzymology, (19890000), vol. 121, pages 663 - 669
    - BIRD, R. E. et al., TIBTECH, (19910000), vol. 9, pages 132 - 137
    - CARTER et al., Bio/Technology, (19920000), vol. 10, pages 163 - 167
    - P. HOLLIGER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448
    - PLUCKTHUN, The Pharmacology of Monoclonal Antibodies, pringer Verlag, (19940000), vol. 113, pages 269 - 315
    - HUSTON, J. S. et al., Proc. Natl. Acad. Sci. U.S.A, (19880000), vol. 85, pages 5879 - 5883
    - Remington's Pharmaceutical Science, Mark Publishing Company
    - LANGER et al., J. Biomed. Mater. Res., (19810000), vol. 15, pages 167 - 277
    - LANGER, Chem. Tech., (19820000), vol. 12, pages 98 - 105
    - SIDMAN et al., Biopolymers, (19830000), vol. 22, pages 547 - 556
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.